Atea Pharmaceuticals Inc

NASDAQ:AVIR   4:00:00 PM EDT
4.80
+0.02 (+0.42%)
4:15:40 PM EDT: $4.80 0.00 (0.00%)
Earnings Announcements

Atea Pharmaceuticals Reports Third Quarter 2022 Financial Results

Published: 11/07/2022 22:29 GMT
Atea Pharmaceuticals Inc (AVIR) - Atea Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update.
Atea Pharmaceuticals Inc - Qtrly Loss per Share $0.10.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.45

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.58

More details on our Analysts Page.